Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.59%
#2 Venom Venom +24.69%
#3 Decred Decred +10.82%
#4 DexNet DexNet +7.57%
#5 TRIA TRIA +6.91%
#6 Status Status +6.45%
#7 Wibx Wibx +5.98%
#8 SkyAI SkyAI +5.16%
#9 Talus Network Talus Network +4.56%
#10 Audiera Audiera +4.30%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Finch Therapeutics Group, Inc. Finch Therapeutics Group, Inc.

Finch Therapeutics Group, Inc.

FNCH
Classement en actions #30545
Finch Therapeutics is a microbiome technology company with a portfolio of... Finch Therapeutics is a microbiome technology company with a portfolio of intellectual property and microbiome assets. The company is now focused on realizing the value of its intellectual property estate and other assets, while supporting the advancement of its microbiome technology through partnerships and collaborations after winding down development efforts.
Prix de l'action
$10.20
Dernière synchronisation: 2026-08-05
Capitalisation boursière
$16.38M
Changement (1 jour)
2.00%
Changement (1 an)
-18.40%
Pays
US
Échange Finch Therapeutics Group, Inc. (FNCH)

Catégorie

Healthcare
Historique du prix de l'action pour Finch Therapeutics Group, Inc. (FNCH)
Prix de clôture le plus élevé : $10.20 le 2026-08-01

Prix de clôture le plus bas : $509.37 le 2021-03-01
Historique du prix de l'action de Finch Therapeutics Group, Inc. de 2021 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -13.21%
2025 19.77%
2024 211.15%
2023 -82.69%
2022 -93.58%
2021 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.89 35.09%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $996.61 51.72%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $116.13 -20.22%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $735.86 6.07%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $257.75 14.92%
BE